Bosch Healthcare Solutions GmbH
09.01.2025 - 11:00
Waiblingen (ots) - The test covers the most important bacterial pathogens across all age groups with a single cartridge - The Vivalytic test is a PCR rapid test that specifically detects the six most common causes of bacterial meningitis in under an ...
To the press release of Bosch Healthcare Solutions GmbH03.09.2024 - 11:10
Waiblingen (ots) - - The Vivalytic test is the world's first PCR test for near-patient testing to specifically detect all three whopping cough pathogens: B. pertussis, B. parapertussis, B. holmesii - Pathogen differentiation is crucial for targeted ...
To the press release of Bosch Healthcare Solutions GmbH18.07.2024 - 11:05
Waiblingen, Germany (ots) - - The Vivalytic test is the first test to specifically detect 3 of the most important gastroenteristis pathogens: Clostridioides difficile, norovirus, and rotavirus. - Clostridioides difficile infection rates are on the ...
To the press release of Bosch Healthcare Solutions GmbH16.05.2024 - 10:05
Waiblingen (ots) - - Vivalytic test detects Candida auris in under an hour at the point of care, making it the world’s first test suitable for screenings. - Candida auris infection rates are on the rise in Germany and can cause severe infections, ...
To the press release of Bosch Healthcare Solutions GmbH18.04.2024 - 10:15
Darmstadt, Gerlingen, and Waiblingen, Germany (ots) - Plans to use innovative Bosch BioMEMS technology in PCR tests for multiresistant bacteria - Bosch and R-Biopharm are jointly investing 150 million euros in the development of new PCR tests and in ...
To the press release of Bosch Healthcare Solutions GmbH10.04.2024 - 14:05
Waiblingen (ots) - - Bosch and Randox Laboratories Ltd. enter partnership for Vivalytic analysis platform to jointly invest around 150 million euros. - First test to feature novel BioMEMS technology will be a highly multiplexing sepsis IVD grade ...
To the press release of Bosch Healthcare Solutions GmbH